uPAR: a versatile signalling orchestrator
F Blasi, P Carmeliet - Nature reviews Molecular cell biology, 2002 - nature.com
The plasminogen system has been implicated in clot lysis, wound healing, tissue
regeneration, cancer and many other processes that affect health and disease. The …
regeneration, cancer and many other processes that affect health and disease. The …
suPAR: the molecular crystal ball
M Thunø, B Macho, J Eugen-Olsen - Disease markers, 2009 - Wiley Online Library
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and
elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in …
elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in …
MicroRNA: biogenesis, function and role in cancer
LA MacFarlane, PR Murphy - Current genomics, 2010 - ingentaconnect.com
MicroRNAs are small, highly conserved non-coding RNA molecules involved in the
regulation of gene expression. MicroRNAs are transcribed by RNA polymerases II and III …
regulation of gene expression. MicroRNAs are transcribed by RNA polymerases II and III …
[HTML][HTML] MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs that target
protein-coding mRNAs at the post-transcriptional level. Our previous studies suggest that mir …
protein-coding mRNAs at the post-transcriptional level. Our previous studies suggest that mir …
[HTML][HTML] Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy
AG Bharadwaj, RW Holloway, VA Miller, DM Waisman - Cancers, 2021 - mdpi.com
Simple Summary In this review, we present a detailed discussion of how the plasminogen-
activation system is utilized by tumor cells in their unrelenting attack on the tissues …
activation system is utilized by tumor cells in their unrelenting attack on the tissues …
[HTML][HTML] Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review
Y Backes, KF van der Sluijs, DP Mackie, F Tacke… - Intensive care …, 2012 - Springer
Purpose Systemic levels of soluble urokinase-type plasminogen activator receptor (suPAR)
positively correlate with the activation level of the immune system. We reviewed the …
positively correlate with the activation level of the immune system. We reviewed the …
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
JA Foekens, HA Peters, MP Look, H Portengen… - Cancer research, 2000 - AACR
The antigen levels of components of the urokinase-type plasminogen activator (uPA) system
of plasminogen activation are correlated with prognosis in several types of cancers …
of plasminogen activation are correlated with prognosis in several types of cancers …
Evolving role of uPA/uPAR system in human cancers
K Dass, A Ahmad, AS Azmi, SH Sarkar… - Cancer treatment …, 2008 - Elsevier
Recent advancements in cancer research have led to some major breakthroughs; however,
the impact on overall cancer-related death rate remains unacceptable, suggesting that …
the impact on overall cancer-related death rate remains unacceptable, suggesting that …
The urokinase plasminogen activator system: role in malignancy
MJ Duffy - Current pharmaceutical design, 2004 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system consists of the serine protease uPA, its
glycolipid-anchored receptor, uPAR and its 2 serpin inhibitors, plasminogen activator …
glycolipid-anchored receptor, uPAR and its 2 serpin inhibitors, plasminogen activator …
The urokinase plasminogen activator system: a target for anti-cancer therapy
S Ulisse, E Baldini, S Sorrenti… - Current cancer drug …, 2009 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system (uPAS) consists of the uPA, its cognate
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …